Current role
Matthew Kinn
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthew Kinn
Recursion Pharmaceuticals, Inc. reported in an 8-K filed November 20, 2024 that Matthew Kinn was appointed Chief Business Officer, effective November 20, 2024. Recursion Pharmaceuticals, Inc. reported in an 8-K filed February 7, 2024 that Matthew Kinn was appointed Senior Vice President, Business Development and Corporate Initiatives, effective February 6, 2024.
“Matthew Kinn, Senior Vice President, Business Development and Corporate Initiatives, was promoted to serve as Chief Business Officer of the Company.”
“Also on February 6, 2024, Matthew Kinn, Senior Vice President, Business Development and Corporate Initiatives joined Recursion's executive team and assumed all responsibilities previously held by Dr. Virani.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-02-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Recursion Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher C. Gibson CEO, Board Member
- Najat Khan CEO
- Najat Khan, Ph.D. CEO, Board Member
- Christopher Gibson, Ph.D. Chairman
- Robert Hershberg, M.D., Ph.D. Chairman
- Ben Taylor CFO
- Kristen Rushton COO
- Tina Marriott COO
- David Hallett CTO, Board Member
- Blake Borgeson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.